Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhawanjit K Brar

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Recent Progress in Hormone Research|January 30, 2004
Essential roles of Her2/erbB2 in cardiac development and functionAlejandra Negro, Bhawanjit K Brar, Kuo-Fen Lee
Endocrinology|December 13, 2003
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptidesBhawanjit K Brar, Alon Chen, Marilyn H Perrin, et al.
Journal of Molecular and Cellular Cardiology|May 7, 2002
Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell deathBhawanjit K Brar, Anastasis Stephanou, Richard Knight, et al.
Regulatory Peptides|January 3, 2012
Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signalingAnne K Jonassen, Anita Wergeland, Erik Helgeland, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
erbB2 is required for G protein-coupled receptor signaling in the heartAlejandra Negro, Bhawanjit K Brar, Yusu Gu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 13, 2008
Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heartRosa Mazza, Alfonsina Gattuso, Cinzia Mannarino, et al.
Cytokine|May 25, 2002
Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytesJulia E Railson, Zhihong Liao, Bhawanjit K Brar, et al.
Regulatory Peptides|July 27, 2010
Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heartBhawanjit K Brar, Erik Helgeland, Sushil K Mahata, et al.
Cardiovascular Research|March 30, 2002
Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusionZhihong Liao, Bhawanjit K Brar, Qing Cai, et al.
Endocrinology|June 7, 2008
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropismTommaso Angelone, Anna Maria Quintieri, Bhawanjit K Brar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Recent Progress in Hormone Research|January 30, 2004
Essential roles of Her2/erbB2 in cardiac development and functionAlejandra Negro, Bhawanjit K Brar, Kuo-Fen Lee
Endocrinology|December 13, 2003
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptidesBhawanjit K Brar, Alon Chen, Marilyn H Perrin, et al.
Journal of Molecular and Cellular Cardiology|May 7, 2002
Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell deathBhawanjit K Brar, Anastasis Stephanou, Richard Knight, et al.
Regulatory Peptides|January 3, 2012
Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signalingAnne K Jonassen, Anita Wergeland, Erik Helgeland, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
erbB2 is required for G protein-coupled receptor signaling in the heartAlejandra Negro, Bhawanjit K Brar, Yusu Gu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 13, 2008
Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heartRosa Mazza, Alfonsina Gattuso, Cinzia Mannarino, et al.
Cytokine|May 25, 2002
Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytesJulia E Railson, Zhihong Liao, Bhawanjit K Brar, et al.
Regulatory Peptides|July 27, 2010
Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heartBhawanjit K Brar, Erik Helgeland, Sushil K Mahata, et al.
Cardiovascular Research|March 30, 2002
Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusionZhihong Liao, Bhawanjit K Brar, Qing Cai, et al.
Endocrinology|June 7, 2008
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropismTommaso Angelone, Anna Maria Quintieri, Bhawanjit K Brar, et al.
Pageof 2